Clinical Proteomics
News on proteomics applications for clinical use in genetics, genomics, and molecular diagnostics.
The firm also spoke about the need to interact with the FDA to clarify how to get its SomaSignal assay for cardiovascular events into clinical trials.
By the end of the year, SomaLogic plans to add 10 more SomaScan diagnostic assays, CEO Roy Smythe told investors, bringing the total to around 30 assays.
BioMérieux Gets FDA 510(k) Clearance for MALDI-TOF Bacterial ID System
The next-generation system, which received CE marking last year, identifies bacteria more rapidly and is now commercially available in the US.
Sera Prognostics Goes Public With $75M IPO
The firm is offering 4,687,500 shares of its common stock at $16 per share. Its first commercial product is the PreTRM test for predicting the risk of a preterm birth.
The team and its partner SpectraPass are creating an assay with the intent of obtaining Emergency Use Authorization from the US Food and Drug Administration.